Gemstone Biotherapeutics Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Employees
  • 2

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $250K

  • Investors
  • 3

Gemstone Biotherapeutics General Information

Description

Developer of advanced wound care technologies designed to repair physiological deficiencies in acute and chronic wounds. The company offers polymeric hydrogels and stem cell engineering methodologies, enabling patients with rapid and cost-effective wound healing with improved clinical outcomes.

Contact Information

Website
www.gemstonebio.com
Formerly Known As
Chiron Labs, Hydro3Labs, Gemstone Therapeutics
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 180 West Ostend Street
  • Suite 277A
  • Baltimore, MD 21230
  • United States
+1 (443)
Primary Industry
Biotechnology
Vertical(s)
HealthTech, Life Sciences
Corporate Office
  • 180 West Ostend Street
  • Suite 277A
  • Baltimore, MD 21230
  • United States
+1 (443)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Gemstone Biotherapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC 28-Aug-2019 $250K Completed Generating Revenue
6. Accelerator/Incubator 01-Jan-2019 Completed Generating Revenue
5. Grant 22-Jun-2018 Completed Generating Revenue
4. Early Stage VC 27-Oct-2016 Completed Generating Revenue
3. Seed Round 08-Jun-2015 Completed Generating Revenue
2. Accelerator/Incubator 05-Feb-2015 $850K $850K Completed Generating Revenue
1. University Spin-Out 01-Jan-2013 Completed Startup
To view Gemstone Biotherapeutics’s complete valuation and funding history, request access »

Gemstone Biotherapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of advanced wound care technologies designed to repair physiological deficiencies in acute and chronic wounds.
Biotechnology
Baltimore, MD
2 As of 2024

Mont-Saint-Guibert, Belgium
 

Mont-Saint-Guibert, Belgium
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Gemstone Biotherapeutics Competitors (17)

One of Gemstone Biotherapeutics’s 17 competitors is NOVADIP, a Venture Capital-Backed company based in Mont-Saint-Guibert, Belgium.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
NOVADIP Venture Capital-Backed Mont-Saint-Guibert, Belgium
Cellaion Formerly VC-backed Mont-Saint-Guibert, Belgium
VivoSim Labs Formerly VC-backed San Diego, CA
Histogen Formerly VC-backed San Ramon, CA
IFM Therapeutics Venture Capital-Backed Boston, MA
You’re viewing 5 of 17 competitors. Get the full list »

Gemstone Biotherapeutics Patents

  • 2

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • Pending

  • Expiring in next 12 mo

Gemstone Biotherapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2020264327-A1 Extracellular matrices, uses thereof, and methods of making extracellular matrices Inactive 26-Jun-2019
WO-2019133823-A1 Extracellular matrices, uses thereof, and methods of making extracellular matrices Inactive 28-Dec-2017

Gemstone Biotherapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Gemstone Biotherapeutics Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
The University System of Maryland Momentum Fund Venture Capital Minority
Springboard Enterprises Accelerator/Incubator Minority
Johns Hopkins University University
To view Gemstone Biotherapeutics’s complete investors history, request access »

Ready to get started?

Request a free trial

Gemstone Biotherapeutics FAQs

  • When was Gemstone Biotherapeutics founded?

    Gemstone Biotherapeutics was founded in 2013.

  • Where is Gemstone Biotherapeutics headquartered?

    Gemstone Biotherapeutics is headquartered in Baltimore, MD.

  • What is the size of Gemstone Biotherapeutics?

    Gemstone Biotherapeutics has 2 total employees.

  • What industry is Gemstone Biotherapeutics in?

    Gemstone Biotherapeutics’s primary industry is Biotechnology.

  • Is Gemstone Biotherapeutics a private or public company?

    Gemstone Biotherapeutics is a Private company.

  • What is Gemstone Biotherapeutics’s current revenue?

    The current revenue for Gemstone Biotherapeutics is .

  • How much funding has Gemstone Biotherapeutics raised over time?

    Gemstone Biotherapeutics has raised $4.25M.

  • Who are Gemstone Biotherapeutics’s investors?

    The University System of Maryland Momentum Fund, Springboard Enterprises, and Johns Hopkins University have invested in Gemstone Biotherapeutics.

  • Who are Gemstone Biotherapeutics’s competitors?

    NOVADIP, Cellaion, VivoSim Labs, Histogen, and IFM Therapeutics are some of the 17 competitors of Gemstone Biotherapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process